- Exchange: SIX Swiss Ex
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Newron Pharmaceuticals SpA
+ Add to WatchlistNWRN:SW
8.16 CHF 0.09 1.09%As of 09:37:22 ET on 05/23/2013.
Company Profile for Newron Pharmaceuticals SpA (NWRN)
Newron Pharmaceuticals SpA is a research and development biopharmaceutical company. The Company focuses on and develops therapies for the Central Nervous System (CNS) in cases such as Parkinson's disease, neuropathic low back pain and other cognitive disorders.
Contact Information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso (Mi), 20091
Italy
Key Executives for Newron Pharmaceuticals SpA (NWRN)
| Stefan WeberCEO/CFO | Ravi AnandChief Medical Officer |
| Marco CaremiVP:Strg Mktg/Head:Legal |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page